文献速递母胎医学产科

孤立性颈项透明层增厚胎儿中二代测序的诊断率:系统综述与荟萃分析

Diagnostic yield of next-generation sequencing in fetuses with isolated increased nuchal translucency: systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2022-01-01

结果显示ES/GS的汇总增量诊断率为4%(95%CI 2-6%),15例检出致病或可能致病变异,其中6例NT≥5mm。

要点

  • NT>99th百分位且无其他异常的胎儿中,ES/GS较CMA的增量诊断率为4%(95%CI 2-6%)。
  • 检出的15例致病变异中,6例(40%)NT≥5mm,遗传模式以常染色体显性为主(12例)。
  • 尚不明确将NT截断值提高至3.5mm以上是否更利于筛选ES/GS适用病例。

核心结论

  • 在NT>99th百分位且不伴其他异常的胎儿中,ES/GS较CMA的增量诊断率为4%(95%CI 2-6%)。
  • 尚不明确NT截断值高于3.5mm是否更有助于选择ES/GS检测病例。

研究设计与样本

  • 系统综述与荟萃分析,遵循PRISMA标准,检索PubMed、Scopus和Web of Science。
  • 采用随机效应模型(按方差倒数加权)进行单比例分析,评估合并效应量。

主要发现

  • 15例胎儿经ES/GS检出致病或可能致病且与表型相关的变异,汇总增量诊断率为4%(95%CI 2-6%)。
  • 15例中6例(40%)NT≥5mm。
  • 遗传模式:常染色体显性12例(含4例Noonan综合征),常染色体隐性2例,X连锁1例。
  • 所有纳入研究经STARD标准评估均为高质量。

关键数值与推荐

  • 纳入标准:英文发表;NT>99th百分位且无伴随异常的胎儿超过2例;CMA阴性作为参考标准。
  • 仅计入ES/GS检出的可能致病或致病且判定为导致胎儿表型的阳性变异。

临床怎么用

  • 对NT>99th百分位且CMA阴性的孤立性NT增厚胎儿,可考虑ES/GS以额外检出约4%的致病变异。
  • 遗传咨询时应告知ES/GS的增量诊断率及常染色体显性遗传模式(含Noonan综合征)的可能性。

局限性

  • 尚不明确NT截断值高于3.5mm是否更利于选择ES/GS检测病例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the diagnostic yield of exome or genome sequencing (ES/GS) over chromosomal microarray analysis (CMA) in fetuses with increased nuchal translucency (NT) and no concomitant anomalies. METHODS: This systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria. PubMed, Scopus and Web of Science were searched for studies describing ES/GS in fetuses with isolated increased NT. Inclusion criteria were: (1) study written in English; (2) more than two fetuses with increased NT > 99th percentile and no concomitant anomalies; and (3) a negative CMA result considered as the reference standard. Only positive variants identified on ES/GS that were classified as likely pathogenic or pathogenic and determined to be causative of the fetal phenotype were considered. Risk was assessed as the pooled effect size by single-proportion analysis using random-effects modeling (weighted by inverse of variance). RESULTS: Eleven studies reporting on the diagnostic yield of ES/GS in fetuses with isolated increased NT > 99th percentile were identified and included 309 cases. All studies were high quality according to Standards for Reporting of Diagnostic Accuracy. Overall, a pathogenic or likely pathogenic variant was identified on ES/GS in 15 fetuses, resulting in a pooled incremental yield of 4% (95% CI, 2-6%). Six (40%) of these fetuses had NT of 5 mm or more. The observed inheritance pattern was autosomal dominant in 12 cases, including four fetuses with Noonan syndrome, autosomal recessive in two cases and X-linked in one case. CONCLUSIONS: There is a 4% incremental diagnostic yield of ES/GS over CMA in fetuses with increased NT > 99th percentile without a concomitant anomaly. It is unclear whether a NT cut-off higher than 3.5 mm may be more useful in case selection for ES/GS. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Pauta M, Martinez-Portilla RJ, Borrell A, et al. Diagnostic yield of next-generation sequencing in fetuses with isolated increased nuchal translucency: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022. PMID: 34309942. doi:10.1002/uog.23746

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。